3 Stocks To Beat The FTSE 100: Unilever plc, AstraZeneca plc And British American Tobacco plc

These 3 shares could outperform the wider index: Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and British American Tobacco plc (LON: BATS)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

Over the last month, the FTSE 100 has fallen by 4.5%. This is a significant fall in a short period of time and shows that, while the global economy may be moving in the right direction, stock market corrections are a very real threat to investors.

Indeed, recent weeks have seen the FTSE 100 become much more volatile, with 50+ points being added/removed from the index on a daily basis.

With this in mind, here are three stocks that not only have bright futures and trade at attractive prices, but also offer relative stability during a highly uncertain period. As a result, they could beat the FTSE 100 moving forward.

Unilever

One of the key attractions of Unilever (LSE: ULVR) (NYSE: UL.US) is its sheer diversity. Of course, that’s not only in regard to its global footprint, with Unilever operating in all corners of the world, but also with a view to its wide range of brands.

Indeed, it sells all manner of consumer goods: from margarine to shampoo. As a result, it tends to offer relatively stable top- and bottom-line numbers that could prove to be major assets during uncertain economic periods.

Furthermore, Unilever has considerable growth potential. With around 60% of its revenue being derived from emerging markets, it should beat the index average when it comes to bottom line growth and, in addition, its current price to earnings (P/E) ratio of 19.8 is low by historical standards.

AstraZeneca

Clearly, the performance of a pharmaceutical company is less dependent upon the performance of the wider economy. So, it’s of little surprise that AstraZeneca (LSE: AZN) (NYSE: AZN.US) is classed as a defensive stock.

However, there’s much more to the company than just a defensive play. Certainly, its pipeline has disappointed in recent years but, after numerous acquisitions, it now has huge potential. For example, the purchase of Bristol-Myers Squibb’s share of the diabetes joint venture could prove to be a masterstroke as the number of diabetes cases worldwide is expected to increase at a rapid rate.

Despite this potential, AstraZeneca trades on a P/E ratio of just 16. While higher than the wider market, this valuation remains relatively attractive when compared to its sector rivals.

British American Tobacco

With tobacco sales being very consistent, British American Tobacco (LSE: BATS) is a great place to invest when the outlook is uncertain for the wider stock market. Indeed, with a beta of just 0.8, British American Tobacco should provide a relatively less volatile experience moving forward.

However, with considerable growth potential in its e-cigarette subsidiary, Nicoventures, British American Tobacco could prove to be more than just a defensive play. Furthermore, with a yield of 4.2% and a long track record of strong dividend growth, it could marry income and reliable growth to provide a potent combination.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca, British American Tobacco and Unilever. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »